LipoScience(LPDX)- NASDAQ
LPDX is defunct.
  • Sep. 25, 2014, 7:40 AM
    • LabCorp (NYSE:LH) acquires LipoScience (NASDAQ:LPDX) for $5.25 per share in cash (transaction value: $85.3M). The transaction will be accretive to earnings in year one and accretive to cost of capital by year three.
    • LipoScience develops diagnostic tests based on nuclear magnetic resonance (NMR). Its first product, the NMR LipoProfile test, directly quantifies LDL particle number (LDL-P) and provides physicians and patients with actionable information to personalize management of heart disease.
    • LPDX is up 64% premarket on high volume.
    | Sep. 25, 2014, 7:40 AM